SVP & CCSO Zahurancik John sold $754,703 worth of shares (31,974 units at $23.60), decreasing direct ownership by 31% to 71,171 units (SEC Form 4)
4 - Fluence Energy, Inc. (0001868941) (Issuer)
Live Feed
Delayed 3mAnalyst · Insider · Buys · SEC · FDA · Financials
Signed out · 3-min delay · Sign up for real-time
- SEC Form 4 filed by Chief Accounting Officer Osben Teo
4 - Ralliant Corp (0002041385) (Issuer)
- SEC Form 4 filed by SVP - Chief Technology Officer Kazmi Amir A.
4 - Ralliant Corp (0002041385) (Issuer)
- Director Subin Neil S converted options into 502,707 shares and exercised 250,000 in-the-money shares at a strike of $11.50 (SEC Form 4)
4 - NEXTNAV INC. (0001865631) (Issuer)
- SEC Form 4 filed by SVP - Chief People Officer Bick Karen M.
4 - Ralliant Corp (0002041385) (Issuer)
- SEC Form 4 filed by SVP - Chief Financial Officer Reynolds Neill
4 - Ralliant Corp (0002041385) (Issuer)
- SEC Form 4 filed by SVP - Chief Legal Officer Boatman Jonathon E.
4 - Ralliant Corp (0002041385) (Issuer)
- Director Formela Jean Francois sold $2,458,582 worth of shares (171,405 units at $14.34) as part of a pre-agreed trading plan (SEC Form 4)
4 - Korro Bio, Inc. (0001703647) (Issuer)
- SEC Form 4 filed by President and CEO Newcombe Tamara S.
4 - Ralliant Corp (0002041385) (Issuer)
- Co-Founder, Chief U/W Officer Oneill Francis James sold $1,934,011 worth of Class A Common Shares (147,000 units at $13.16) as part of a pre-agreed trading plan (SEC Form 4)
4 - Accelerant Holdings (0001997350) (Issuer)
- SEC Form 144 filed by Quantum-Si Incorporated
144 - Quantum-Si Inc (0001816431) (Subject)
- Director Castellano James G was granted 2,799 shares, increasing direct ownership by 60% to 7,437 units (SEC Form 4)
4 - Core & Main, Inc. (0001856525) (Issuer)
- Director Newman Margaret was granted 2,799 shares, increasing direct ownership by 20% to 16,757 units (SEC Form 4)
4 - Core & Main, Inc. (0001856525) (Issuer)
- Director Hardwick M Susan was granted 2,799 units of Class A Common Stock, increasing direct ownership by 483% to 3,379 units (SEC Form 4)
4 - Core & Main, Inc. (0001856525) (Issuer)
- Director Mazzarella Kathleen M was granted 2,799 shares, increasing direct ownership by 20% to 16,757 units (SEC Form 4)
4 - Core & Main, Inc. (0001856525) (Issuer)
- Chief Medical Officer Dambkowski Carl sold $3,500,640 worth of shares (26,400 units at $132.60) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 179,248 units (SEC Form 4)
4 - Apogee Therapeutics, Inc. (0001974640) (Issuer)